The Long and Short
Weighing risks at Comerica and Zions
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
Two investment grade lenders that have seen tremendous volatility—and likely significant deposit erosion—since the initial start of the banking flare-up are Comerica Inc (A3*-/BBB+/A-) and Zions Bancorporation (ZION: Baa1*-/BBB+/BBB+). Both banks now trade at distressed levels relative to their regional banking peers. But a look at some of the risks that contributed to SIVB and SBNY failures can help put CMA and ZION in context. It appears investors are well-compensated for the risks in these credits and should consider increasing allocation or establishing a position at these unprecedented valuations.
The domestic banking crisis—or perhaps more accurately the banking flare-up—has reached a bit of an impasse. After the collapse SVB Financial (SIVB) and Signature Bank (SBNY), the next layer of “at-risk” banks are contemplating their options, while the market weighs the likelihood of more bank failures. Under the close watch of regulators banks like First Republic (FRC), PacWest (PACW) and Western Alliance (WAL) have been pursuing various solutions to avoid similar fates to SIVB and SBNY. Those include a deposit injection of $30 billion at FRC from 11 larger peer banks, which later was altered to a pure capital injection to help fund any prospective shortfall. PACW tapped roughly $15 billion in government funding options this week plus a $1.4 billion private investment from Atlas SP Partners.
Exhibit 1.
Source: SanCap, Bloomberg/TRACE G-spread indications only
Comerica’s on-the-run 10-year senior unsecured notes, the CMA 5.332% ‘29s, are still trading on a spread basis and currently indicated in a context of +420/410, or about an $85 dollar price and a yield of approximately 7.6%. Zions Bancorp’s subordinated bank note, the ZION 3.25% ‘29s, are indicated in a dollar price range of $65.00/67.50, which works out to a yield north of 10% on either the bid or ask basis. ZION’s bonds were indicated in the mid-$80s just prior to SIVB filing, with the CMA 10-year note in the high-$90s context. While ZION is clearly in more distressed territory, both banks’ current valuations in the debt market seem to appropriately capture the likelihood of regulatory intervention at this phase in the crisis.
Both CMA and ZION were placed on review for downgrade by Moody’s on 03/13/23 along with several other regional banks, shortly after SIVB and SBNY were placed into receivership. In the case of CMA, the rating agency highlighted the bank’s reliance on confidence sensitive uninsured deposit funding, significant unrealized losses in the available-for-sale (AFS) portfolio, and modest levels of overall capital. Specifically, the unrealized AFS losses were estimated to be 38.5% of tier 1 common equity capital. Likewise, ZION was singled out by Moody’s for uninsured deposits, as well as unrealized losses in its securities portfolio that represented 51% of common equity at year-end 2022. S&P has yet to weigh in on either of the lenders since the start of the crisis.
Banks with California footprints were quickly drawn into the fray. While both are located on the Westcoast, neither CMA nor ZION has an operating footprint with the majority of operations located in California, as is the case with SIVB and FRC. CMA is headquartered in Dallas, TX and operates throughout its home state, MI, AZ, and FL in addition to its branches in CA. ZION is based in Salt Lake City, UT, with operations throughout UT, CA, NV, AZ, TX, CO and ID.
Looking first at the securities positions of CMA and ZION as potential risk factors. CMA had no held-to-maturity (HTM) holdings as of year-end 2022, while the fair value AFS holdings were at just over $19 billion, with a net unrealized loss of just over $3 billion. That represented 39% of Tier 1 Common Capital as stated by Moody’s and 74% of Tangible Common Equity. Meanwhile, total securities were a more modest 22% of total assets. For ZION, HTM fair value holdings were just over $11 billion with just under $12 billion in AFS holdings. Net unrealized losses were $1.5 billion, including a $113 million gain on HTM holdings. The net estimated loss represented 23% of Tier 1 Common and 45% of Tangible Common Equity. Total securities represented about 26% of total assets. Both banks’ unrealized losses-to-equity rank on the high side relative to IG peers but consider SIVB’s holdings just prior to collapse. SIVB’s total securities holdings stood at over 55% of total assets. Meanwhile, the nearly $18 billion in total unrealized losses in the securities portfolio represented 149% and 129% of Tangible Common and Tier 1 Common Equity, respectively.
Looking at deposit concentration, SVB Financial was an unique institution. Because of its unique position as a lender to the venture capital industry, an estimated 97% of the bank’s total deposits were uninsured as of year-end 2022. That resulted in an average deposit size of approximately $1.1 million. SBNY’s average deposit size was next largest in the industry at roughly $500K. WAL is next at about $300K and FRC follows at just over $200K. After that the range of outcomes drops off considerably. About 73% of CMA’s deposits are uninsured, which compares to an industry median closer to 53%. ZION is a little bit lower but also high relative to the industry at 66%. Both banks have average deposit size in a very normal range relative to US regional banks with CMA at $60K and ZION at approximately $51K. Most regional banks with reasonably high concentration in commercial depositors fall in a very similar range.
Another factor that is raising concerns across the US banking industry in wake of the recent collapses is the degree to which each individual bank is highly concentrated in commercial real estate (CRE). CRE has long been speculated as a potential area for rapid credit deterioration in the near-to-intermediate term. CMA’s exposure to CRE as a percentage of its total loan book is about 19%, which hardly qualifies as an overexposure to the loan class. Even when adding on the amount of construction and development loans, the total is only about 25.6% of total loans outstanding. ZION’s CRE exposure is about 30% of its total loan book, or 36.6% when including construction and development loans. Neither of these concentrations appear onerously high when compared to the broader IG regional banking peer group.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2025 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
